参考文献/References:
[1] Qin L,Zhang Y,Yang X,et al. Cardiac involvement in primary Sj?gren’s syndrome[J]. Rheumatol Int,2022,42(2):179-189.
[2] 刘汉雄,汪汉. 免疫性心脏病学[M]. 第一版.成都:电子科技大学出版社,2020:90-100.
[3] 汪汉,蔡琳,彭方琴,等. 血尿酸与多发性肌炎患者肺动脉压力的相关性研究[J]. 心肺血管病杂志,2018,37(2):103-106.
[4] 彭方琴,汪汉,蔡琳,等. 糖类抗原125水平与特发性炎性肌病患者肺动脉压的关系研究[J]. 实用心脑肺血管病杂志,2017,25(10):64-67.
[5] 汪汉,刘英杰,王燕凤. 长链非编码RNA与肺动脉高压[J]. 心血管病学进展,2019,40(6):898-901.
[6]彭方琴,汪汉,蔡琳,等. 肿瘤标志物CA125与特发性炎症性肌病合并心包积液的研究[J]. 临床心血管病杂志,2017,33(11):1070-1074.
[7] 中华医学会风湿病学分会. 干燥综合征诊断及治疗指南[J]. 中华风湿病学杂志,2010,14(11):766-768.
[8] Koushik A,Manoj M,Nezamuddin N. Explaining deep learning-based activity schedule models using SHapley Additive exPlanations[J]. Transp Lett,2024,1-16.
[9] Mathai SC. Pulmonary hypertension associated with connective tissue disease[J]. Rheum Dis Clin North Am,2024,50(3):359-379.
[10]Launay D,Hachulla E,Hatron PY,et al. Pulmonary arterial hypertension:a rare complication of primary Sj?gren syndrome:report of 9 new cases and review of the literature[J]. Medicine (Baltimore),2007,86(5):299-315.
[11] Fox RI. The incidence of pulmonary hypertension is higher in systemic lupus and Sj?gren’s patients than in scleroderma patients in China[J]. Lupus,2018,27(7):1051-1052.
[12]Sato T,Hatano M,Iwasaki Y,et al. Prevalence of primary Sj?gren’s syndrome in patients undergoing evaluation for pulmonary arterial hypertension[J]. PLoS One,2018,13(5):e0197297.
[13] Kobak S,Kalkan S,Kirilmaz B,et al. Pulmonary arterial hypertension in patients with primary Sj?gren’s syndrome[J]. Autoimmun Dis,2014,2014:710401.
[14] Goulabchand R,Roubille C,Montani D,et al. Cardiovascular events,sleep apnoea,and pulmonary hypertension in primary Sj?gren’s syndrome:data from the French health insurance database[J]. J Clin Med,2021,10(21):5115.
[15] Chen Z,Tian J,Ouyang R. Clinical characteristics and risk factors for primary Sj?gren’s syndrome complicated with pulmonary arterial hypertension[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2023,48(3):339-346.
[16] Zhang N,Zhao Y,Wang H,et al. Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sj?gren’s syndrome:15 new cases from a single center[J]. Int J Rheum Dis,2019,22(9):1775-1781.
[17] Yan S,Li M,Wang H,et al. Characteristics and risk factors of pulmonary arterial hypertension in patients with primary Sj?gren’s syndrome[J]. Int J Rheum Dis,2018,21(5):1068-1075.
[18] Zhang Y,Jin Q,Zhao Z,et al. Carbohydrate antigen 125 is a biomarker of the severity and prognosis of pulmonary hypertension[J]. Front Cardiovasc Med,2021,8:699904.
[19] Liu Z,Yang X,Tian Z,et al. The prognosis of pulmonary arterial hypertension associated with primary Sj?gren’s syndrome:a cohort study[J]. Lupus,2018,27(7):1072-1080.
[20] Eiras S,de la Espriella R,Fu X,et al. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers[J]. J Transl Med,2024,22(1):619.
[21] Li M,Shi Y,Zhao J,et al. Identification of potential susceptibility genes in patients with primary Sj?gren’s syndrome-associated pulmonary arterial hypertension through whole exome sequencing[J]. Arthritis Res Ther,2023,25(1):175.
[22] Bersohn M,Shapiro S,Turner M,et al. Prognostic value of heart rate and systemic blood pressure in pulmonary arterial hypertension[J]. J Am Coll Cardiol,2010,55(10):A154.E1443.
[23] Snipelisky D,Jentzer J,Batal O,et al. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension[J]. Clin Cardiol,2018,41(6):782-787.
[24] Cheron C,McBride SA,Antigny F,et al. Sex and gender in pulmonary arterial hypertension[J]. Eur Respir Rev,2021,30(162):200330.